Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-20 of 74   Next >
 
3.  
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 Jul 1. NGC:010480
American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Professional Association. View all guidelines by the developer(s)
5.  
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 Jul 1. NGC:010478
American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Professional Association. View all guidelines by the developer(s)
6.  
8.  
MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction. 2007 May (revised 2013 Nov). NGC:010185
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11.  
13.  
Nonnutritive sweeteners: current use and health perspectives: a scientific statement from the American Heart Association and the American Diabetes Association. 2012 Jul 24. NGC:009320
American Diabetes Association - Professional Association; American Heart Association - Professional Association. View all guidelines by the developer(s)
14.  
European guidelines on cardiovascular disease prevention in clinical practice (version 2012). 2003 Dec (revised 2012 Jul). NGC:009545
European Society of Cardiology - Medical Specialty Society. View all guidelines by the developer(s)
15.  
The Clinical Pharmacogenetics Implementation Consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. 2012 Jul. [NGC Update Pending] NGC:009589
Clinical Pharmacogenetics Implementation Consortium - Independent Expert Panel. View all guidelines by the developer(s)
16.  
Guidelines for the management of absolute cardiovascular disease risk. 2009 (revised 2012 May). NGC:010370
National Stroke Foundation (Australia) - Nonprofit Organization. View all guidelines by the developer(s)
17.  
The 2012 hormone therapy position statement of The North American Menopause Society. 2002 Oct 6 (revised 2012 Mar). NGC:008998
The North American Menopause Society - Nonprofit Organization. View all guidelines by the developer(s)
19.  
1-20 of 74   Next >